Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis

Annals of Neurology

Volumn 42, Issue 1, 1997, Pages 74-84

  Bonetti, Bruno ^a,b   Raine, Cedric S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b POLICLINICO BORGO ROMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; ASTROCYTE; CELL DEATH; CELL POPULATION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROGLIA; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; DNA FRAGMENTATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0030738366     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420113     Document Type: Article

References (52)

1. Raine CS. Demyelinating diseases. In: Davis RL, Robertson DM, eds. Textbook of neuropathology. 3rd ed. Baltimore: Williams & Wilkins, 1997:627-714
2. Prineas JW. The neuropathology of multiple sclerosis. In: Koetsier JC, ed. Handbook of clinical neurology, vol 47. Demyelinating diseases. Amsterdam: Elsevier Science, 1985:213-257
3. Williams KC, Ulvestad E, Hickey WF. Immunology of multiple sclerosis. Clin Neurosci 1994;2:229-245
4. Raine CS. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 1994;36: 561-572
5. McFarlin DE, McFarland HF. Multiple sclerosis. N Engl J Med 1982;307:1183-1188, 1246-1251
6. Oksenberg JR, Panzara MA, Begovich AB, et al. Selection for T cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993;362:68-70
7. Wucherpfennig KW, Ota K, Endo N, et al. Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 1990;248:1016-1019
8. Lee SC, Raine CS. Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules. J Neuroimmunol 1989;25:261-266
9. 14C-labeled cells during acute, chronic and relapsing experimental allergic encephalomyelitis. Lab Invest 1990;63:162-170
10. Raine CS, Scheinberg L, Waltz JM. Multiple sclerosis: oligodendrocyte survival and proliferation in an active, established lesion. Lab Invest 1981;45:534-546
11. Raine CS. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 1984;50:608-635
12. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 1993;68:627-636
13. Ozawa K, Suchanek G, Breitschopf H, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994;117: 1311-1322
14. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-274
15. Cohen JJ. Apoptosis. Immunol Today 1993;14:126-130
16. Nagata S, Golstein P. The Fas death factor. Science 1995;267: 1449-1456
17. Korsmeyer SJ. Regulators of cell death. Trends Genet 1995;11: 101-105
18. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501
19. Wijsman JH, Jonker RR, Keijzer R, et al. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12
20. Gold R, Schmied M, Giegerich G, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994; 71:219-225
21. Thompson CG. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462
22. Beutler B, van Huffel C. Unraveling function in the TNF ligand and receptor families. Science 1994;264:667-668
23. Bazzoni F, Beutler B. How do tumor necrosis factor receptors work? J Inflam 1995;45:221-238
24. Vandanabeele P, Declercq W, Beyaert R, Fiers W. Two tumor necrosis factor receptors: structure and functions. Trends Biochem Sci 1995;5:392-399
25. Higuchi M, Aggarwal BB. Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation, and differentiation. J Immunol 1994;152:4017-4025
26. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243
27. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995;16:569-574
28. Takashi S, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994;179:873-879
29. Watanabe-Fukunaga R, Brannan CI, Itoh N, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279
30. Bellgrau D, Gold D, Selawry H, et al. A role for CD95 ligand in preventing graft rejection. Nature 1995;377:630-632
31. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270:1189-1192
32. Tanaka M, Suda S, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995;14:1129-1135
33. Tanaka M, Suda T, Haze K, et al. Fas ligand in human sera. Nat Med 1996;2:317-322
34. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989;170:607-612
35. Selmaj KW, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991;87:949-954
36. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23: 339-346
37. Wilt SG, Milward E, Zhou JM, et al. In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type-1 encephalopathy. Ann Neurol 1995;37:381-394
38. D'Souza S, Alinauskas K, McCrea E, et al. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci 1995;15:7293-7300
39. D'Souza SD, Balasingam V, Cashman NR, et al. Susceptibility of human oligodendrocytes to Fas-mediated injury. Neurology 1996;46:S466
40. D'Souza SD, Bonetri B, Balasingam V, et al. Multiple sclerosis: fas signalling in oligodendrocyte cell death. J Exp Med 1996; 184:2361-2370
41. Raine CS, Johnson AB, Marcus DM, et al. Demyelination m vitro: absorption studies demonstrate that galactocerebroside is a major target. J Neurol Sci 1981;52:117-131
42. Tchelingerian JL, Monge M, Le Saux F, et al. Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. J Neurochem 1995;65:2377-2380
43. Raine CS, Scheinberg LC. On the immunopathology of plaque development and repair in multiple sclerosis. J Neuroimmunol 1988;20:189-201
44. Raff MC, Barres BA, Burne JF, et al. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 1993;262:695-700
45. Louis JC, Magal E, Takayama S, Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 1993;259:689-692
46. D'Souza SD, Alinauskas KA, Antel JP. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 1996;43:289-298
47. Vandenabeele P, Declercq W, Vanhaesebroek B, et al. Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 1995;154:2904-2913
48. Zipp F, Weller M, Dichgans J, Martin R. Autoreactive T cells of multiple sclerosis patients and healthy individuals are resistant to apoptosis by soluble Fas ligand. Neurology 1996;46: S279
49. Schmied M, Breitschopf H, Gold R, et al. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993;143:446-452
50. McCombe PA, Nickson I, Tabi Z, Pender MP. Apoptosis of Vβ8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neurol Sci 1996;139:1-6
51. Bonetti B, Raine CS. Bcl-2 and Fas system molecule expression in multiple sclerosis lesions. J Neuropathol Exp Neurol 1996; 55:641
52. Brosnan CF, Claudio L, Martiney JA. The blood-brain barrier during immune responses. Semin Neurosci 1992;4:193-200